COMMUNIQUÉS West-GlobeNewswire

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
25/08/2026
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 25 août 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Paris / Nasdaq Euronext [...]
Voting Rights and Shares Capital of the Company
25/08/2026
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, Aug. 25, 2026 (GLOBE NEWSWIRE [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
25/08/2026
NOVATO, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare [...]
Informations sur le nombre total de droits de vote et d'actions
25/08/2026
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 25 aout 2026, 22h30 CET / 16h30 ET – Conformément à l'article 15 de la loi du 2 mai 2007 relative [...]
Information on the total number of voting rights and shares
25/08/2026
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), August 25, 2026 , 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the [...]
VapoCept Capsule Label Guide: What the Supplement Facts Panel, Serving Directions, and Safety Statements Disclose for 2026
25/08/2026
L-Arginine, L-Citrulline, Niacin, and Beta-Alanine amounts, nitric oxide pathway sourcing, and manufacturing standards behind VapoCept's amino acid formula. Ogden, UT, Aug. 25, 2026 (GLOBE NEWSWIRE) -- These statements [...]
Perceptra, a Thai Startup, Brings Medical AI to International Markets to Enhance Regional Patient Screening
25/08/2026
Inspectra Drives Healthcare Innovation in Southeast Asia Singapore, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Perceptra Co., Ltd., a Thai startup developing artificial intelligence technology for medical image analysis, has [...]
University of Miami's Gift of 1994 Ibogaine IND to HHS Sets a Standard for Open Science
25/08/2026
MAPS provided the first outside funding for the University of Miami ibogaine research program in the 1990s The 1994 IND is not a substitute for current safety and sourcing data Earlier this summer, MAPS published its [...]
Le Fonds Rio Tinto Canada investit 2 millions de dollars pour faire avancer l’innovation en santé au Québec
25/08/2026
Le soutien apporté à deux projets novateurs accélérera l’innovation, renforcera les soins aux patients et fera progresser la recherche, à l’échelle mondiale MONTRÉAL, 25 août 2026 (GLOBE NEWSWIRE) -- Le Fonds Rio Tinto [...]
Rio Tinto Canada Fund invests $2 million to advance healthcare innovation in Quebec
25/08/2026
Support for two groundbreaking initiatives will accelerate innovation, strengthen patient care and advance research with global impact MONTREAL, Aug. 25, 2026 (GLOBE NEWSWIRE) -- The Rio Tinto Canada Fund is investing $ [...]
BrewDog cumule les distinctions aux World Beer Awards 2026 et confirme l’excellence de son savoir-faire brassicole
25/08/2026
Les bières Hazy Jane, Wingman et Mackie’s Two Scoops remportent une médaille d’or et le titre de meilleure de leur catégorie en Écosse. Les références Punk IPA, Lost Lager, Black Heart et Mello se distinguent également [...]
Annovis to Host Corporate Update Webinar on September 2, 2026
25/08/2026
MALVERN, Pa., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for [...]
YD Bio Announces Peer-Reviewed Publication in Nutrients, Co-Authored with Physicians from the Taiwan Chronic Disease Healthcare Association and the Future Health Institute
25/08/2026
TAIPEI, Taiwan, Aug. 25, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation–based cancer detection technology and ophthalmologic [...]
CVRx Responds to Letter from Pointillist Family Office
25/08/2026
MINNEAPOLIS, Aug. 25, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Mixie Technologies, Inc. (OTC: MIXE) Portfolio Company HoloTwin Unveils TwinRuntime: Enterprise Digital Twins That Run in a Standard Web Browser, No Downloads Required
25/08/2026
Mixie Technologies' flagship portfolio company milestone caps a year that took HoloTwin from a strategic investment, to a CES 2026 award, to HoloTwin 2.0, and now to a browser-native runtime that puts living digital [...]
Nu-Tek BioSciences to Attend BPI East 2026 in Boston, Connecting Animal-Free Culture Media Nutrients with Pharma Customer Growth Strategies
25/08/2026
Nu-Tek will meet with pharmaceutical leadership during BioProcess International East Sept. 22-25 in Boston to discuss 100% animal-origin-free peptones and protein hydrolysates, with a focus on product quality and supply [...]
Nu-Tek BioSciences participera au salon BPI East 2026 à Boston pour établir des liens entre ses nutriments pour milieux de culture sans composants d’origine animale et les stratégies de croissance de ses clients du secteur pharmaceutique
25/08/2026
Nu-Tek rencontrera des dirigeants de l’industrie pharmaceutique lors du salon BioProcess International East, du 22 au 25 septembre à Boston, afin de discuter de peptones et d’hydrolysats de protéines 100 % sans [...]
Anavex Life Sciences Reports Third Fiscal Quarter 2026 Financial Results and Business Update
25/08/2026
Clinical Development Strategy for Alzheimer’s Disease Remains the Focus as Anavex Advances Regulatory Progress Across All Three Programs Anavex Submits Completed Alzheimer’s Disease Clinical Study Data and Rett Syndrome [...]
4DMT to Participate in Upcoming Investor Conferences
25/08/2026
EMERYVILLE, Calif., Aug. 25, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]

Pages